Evidence map›Paper›PMID 37214454›Full record

SynthesisFrontiers in pharmacology2023

Effects of early adjunctive pharmacotherapy on serum levels of brain injury biomarkers in patients with traumatic brain injury: a systematic review of randomized controlled studies.

Noha O Mansour, Mohamed Hassan Elnaem, Doaa H Abdelaziz, Muna Barakat, Inderpal Singh Dehele, Mahmoud E Elrggal, Mahmoud S Abdallah

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 7 institutions in 5 countries.

Noha O MansourClinical Pharmacy and Pharmacy Practice Department, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
Mohamed Hassan ElnaemSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden, Malaysia.
Doaa H AbdelazizPharmacy Practice and Clinical Pharmacy Department, Faculty of Pharmacy, Future University in Egypt, Cairo, Egypt.
Muna BarakatDepartment of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan.
Inderpal Singh DeheleSchool of Pharmacy, University of Birmingham, Birmingham, United Kingdom.
Mahmoud E ElrggalCollege of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
Mahmoud S AbdallahDepartment of Clinical Pharmacy, Faculty of Pharmacy, University of Sadat City, Sadat City, Egypt.
Future University in Egypt · EGMansoura University · EGMiddle East University · JOUmm al-Qura University · SAUniversiti Sains Malaysia · MYUniversity of Birmingham · GBUniversity of Sadat City · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkersGFAPmemantinemetforminneuron-specific enolaseNSES100 ßUCHL1

Identifiers

PMID37214454
PMCPMC10196026
OpenAlexW4377564809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.